The Global Myasthenia Gravis (MG) Treatment Market size is expected to reach USD 2.06 billion by 2028 at a CAGR of 7% during the forecast period 2022-2028. Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder that weakens the skeletal muscles of the arms and legs. Double vision, facial paralysis, difficulty walking, and drooping eyelids […]
